版本:
中国

BRIEF-Mylan receives tentative approval from U.S. FDA for "TLE400" under PEPFAR

March 20 Mylan NV:

* Mylan receives tentative approval for "TLE400" under PEPFAR

* TLE400 will be available in developing countries as a first-line regimen for people being treated for HIV/AIDS

* Receipt of tentative approval from U.S. FDA under U.S. President's Emergency Plan for AIDS Relief for NDA for TLE400 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐